Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1411 AL 1425

Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards

Picillo M, Kou N, Barone P, Fasano A.

Parkinsonism Relat Disord. 2015 Sep;21(9):1041-8. doi: 10.1016/j.parkreldis.2015.07.018. Epub 2015 Jul 22.

Appendectomy may delay Parkinson's disease Onset

Mendes A, Gonçalves A, Vila-Chã N, Moreira I, Fernandes J, Damásio J, Teixeira-Pinto A, Taipa R, Lima AB, Cavaco S.

Mov Disord. 2015 Sep;30(10):1404-7. doi: 10.1002/mds.26311. Epub 2015 Jul 30.

Comparison of automatic versus manual procedures for the quantification of dopamine D2 receptor availability using I-123-IBZM-SPECT

Heinzel A, Mohammadkhani Shali S, Dafotakis M, Verburg FA, Mottaghy FM, Winz OH.

Nucl Med Commun. 2015 Nov;36(11):1120-6. doi: 10.1097/MNM.0000000000000363.

A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease

Mischley LK, Leverenz JB, Lau RC, Polissar NL, Neradilek MB, Samii A, Standish LJ.

Mov Disord. 2015 Oct;30(12):1696-701. doi: 10.1002/mds.26351. Epub 2015 Jul 31.

A new scale for the assessment of pain in Parkinson's disease

Schrag A.

Mov Disord. 2015 Oct;30(12):1589-90. doi: 10.1002/mds.26353. Epub 2015 Jul 31.

A Prospective Open-Label Study of Combined Treatment for Idiopathic Parkinson's Disease Using Acupuncture and Bee Venom Acupuncture as an Adjunctive Treatment

Doo KH, Lee JH, Cho SY, Jung WS, Moon SK, Park JM, Ko CN, Kim H, Park HJ, Park SU.

J Altern Complement Med. 2015 Oct;21(10):598-603. doi: 10.1089/acm.2015.0078. Epub 2015 Jul 31.

[Progress in Diagnosis and Treatment of Parkinson's Disease]

Nakashima K.

Nihon Naika Gakkai Zasshi. 2015 Aug;104(8):1543-5.

Manganese Toxicity Upon Overexposure: a Decade in Review

O'Neal SL, Zheng W.

Curr Environ Health Rep. 2015 Sep;2(3):315-28. doi: 10.1007/s40572-015-0056-x.

Cholesterol - A putative endogenous contributor towards Parkinson's disease

Paul R, Choudhury A, Borah A.

Neurochem Int. 2015 Nov;90:125-33. doi: 10.1016/j.neuint.2015.07.025. Epub 2015 Jul 29.

Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography

Horti AG.

Biochem Pharmacol. 2015 Oct 15;97(4):566-575. doi: 10.1016/j.bcp.2015.07.030. Epub 2015 Jul 29.

Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program

Odin P, Ray Chaudhuri K, Slevin JT, Volkmann J, Dietrichs E, Martinez-Martin P, Krauss JK, Henriksen T, Katzenschlager R, Antonini A, Rascol O, Poewe W; National Steering Committees.

Parkinsonism Relat Disord. 2015 Oct;21(10):1133-44. doi: 10.1016/j.parkreldis.2015.07.020. Epub 2015 Jul 23.

LRRK2 A419V variant is a risk factor for Parkinson's disease in Asian population

Li K, Tang BS, Liu ZH, Kang JF, Zhang Y, Shen L, Li N, Yan XX, Xia K, Guo JF.

Neurobiol Aging. 2015 Oct;36(10):2908.e11-5. doi: 10.1016/j.neurobiolaging.2015.07.012. Epub 2015 Jul 11.

Psychological Benefits of Nonpharmacological Methods Aimed for Improving Balance in Parkinson's Disease: A Systematic Review

Šumec R, Filip P, Sheardová K, Bareš M.

Behav Neurol. 2015;2015:620674. doi: 10.1155/2015/620674. Epub 2015 Jul 7.

Protective effects of ginseng on neurological disorders

Ong WY, Farooqui T, Koh HL, Farooqui AA, Ling EA.

Front Aging Neurosci. 2015 Jul 16;7:129. doi: 10.3389/fnagi.2015.00129. eCollection 2015.

Using iPS Cells toward the Understanding of Parkinson's Disease

Torrent R, De Angelis Rigotti F, Dell'Era P, Memo M, Raya A, Consiglio A.

J Clin Med. 2015 Mar 30;4(4):548-66. doi: 10.3390/jcm4040548.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias